chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Pyrexia
Clinical narrative: Received COVID vaccine 12/22 at 1100. Noted hive on right wrist, opposite arm of vaccination at 1700; hive- 1 cm in dimeter, red raised in middle, not itchy. Benadryl at bedtime and when woke up red outline was present  but not raised, 24 hours later completely resolved. Some fatigue and slight headache within the first 12 hours, resolved. Also reported mild chills and mild fever lasting less than 12 hours.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Received COVID vaccine 12/22 at 1100. Noted hive on right wrist, opposite arm of vaccination at 1700; hive- 1 cm in dimeter, red raised in middle, not itchy. Benadryl at bedtime and when woke up red outline was present  but not raised, 24 hours later completely resolved. Some fatigue and slight headache within the first 12 hours, resolved. Also reported mild chills and mild fever lasting less than 12 hours.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac flutter, Chills, Hemiparesis, Hypertension, Muscle spasms
Clinical narrative: Excessive thirst 15mins post  Heart palpation with fluttering sensations 30mins post HTN 156/96, 80hr, 1hour post  Chills 1hour post  Muscle spasms with cramping throughout body 45mins post Muscle weakness to left side 2hour post Facial twitches Treated with tylenol and Gatorade and rest. Symptoms lasted 48hours post.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Palindromic rheumatism, Thirst
Clinical narrative: Excessive thirst 15mins post  Heart palpation with fluttering sensations 30mins post HTN 156/96, 80hr, 1hour post  Chills 1hour post  Muscle spasms with cramping throughout body 45mins post Muscle weakness to left side 2hour post Facial twitches Treated with tylenol and Gatorade and rest. Symptoms lasted 48hours post.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Lymph node pain, Mononucleosis heterophile test negative, Pain
Clinical narrative: Vaccinated on 12/23/2020 at 1 PM. Moderate pain and tenderness on injection site. One white pustule on left tonsil. Tender lymph nodes. Moderate generalized body aches. Mild headache, mild fever. Went to urgent care Negative for mono and strep. Got script for erythromycin if symptoms persist.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pustule, Pyrexia, Streptococcus test negative, Tonsillar disorder
Clinical narrative: Vaccinated on 12/23/2020 at 1 PM. Moderate pain and tenderness on injection site. One white pustule on left tonsil. Tender lymph nodes. Moderate generalized body aches. Mild headache, mild fever. Went to urgent care Negative for mono and strep. Got script for erythromycin if symptoms persist.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Cough, Influenza A virus test negative, Influenza B virus test, Influenza virus test negative
Clinical narrative: Developed cough, fever, body aches, and chest pain
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Developed cough, fever, body aches, and chest pain
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Flushing, Heart rate increased
Clinical narrative: Flushed skin, elevated HR, extreme feeling of internal heat, dizzy
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal pain upper, Blood test normal, Chest X-ray normal, Computerised tomogram abdomen, Computerised tomogram normal
Clinical narrative: Employee who received immunization states that at approximately 7:00 pm on night of 12/25/20 she began experiencing stomach pain and nausea and vomited twice. Approximately 2 hours later she noticed hives on back of left arm and on neck and started having difficulty breathing and feeling like tongue and back of throat were swelling. She went to local ER approximately 30 min later. In the ER she was given Benadryl, Zofran, Dexamethasone, Toradol, She states shortly after Benadryl was given she was able to breath more easily and symptoms were significantly reduced in 3-4 hours. She states nausea and stomach pain did continue until 12/26/20
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: Dyspnoea, Electrocardiogram normal, Nausea, Pharyngeal swelling, SARS-CoV-2 test negative
Clinical narrative: Employee who received immunization states that at approximately 7:00 pm on night of 12/25/20 she began experiencing stomach pain and nausea and vomited twice. Approximately 2 hours later she noticed hives on back of left arm and on neck and started having difficulty breathing and feeling like tongue and back of throat were swelling. She went to local ER approximately 30 min later. In the ER she was given Benadryl, Zofran, Dexamethasone, Toradol, She states shortly after Benadryl was given she was able to breath more easily and symptoms were significantly reduced in 3-4 hours. She states nausea and stomach pain did continue until 12/26/20
Age: 21.0
Sex: F
Vaccine: HEP
Symptoms: Swollen tongue, Urticaria, Vomiting
Clinical narrative: Employee who received immunization states that at approximately 7:00 pm on night of 12/25/20 she began experiencing stomach pain and nausea and vomited twice. Approximately 2 hours later she noticed hives on back of left arm and on neck and started having difficulty breathing and feeling like tongue and back of throat were swelling. She went to local ER approximately 30 min later. In the ER she was given Benadryl, Zofran, Dexamethasone, Toradol, She states shortly after Benadryl was given she was able to breath more easily and symptoms were significantly reduced in 3-4 hours. She states nausea and stomach pain did continue until 12/26/20
Age: 17.0
Sex: M
Vaccine: MMRV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: A patient, age 17, was inadvertently administered a dose of PROQUAD; This spontaneous report was received from a certified medical assistant referring to a 17 years old male patient. Information about pertinent medical history, drug reactions or allergies and concomitant medication was not provided.  On 30-NOV-2020, the patient was inadvertently vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (Therapy Type: recombinant Human albumin) (lot # T023917 has been verified to be a valid lot number, expiration date was reported as 09-JAN-2022; strength and route of administration were not reported) 0.5 mL for prophylaxis (inappropriate age at vaccine administration). No additional adverse event or product quality complaint was reported.
Sex: U
Vaccine: HEP
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event; RECOMBIVAX was given after a termperature excursion; This spontaneous report was received from a registered nurse referring to one patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions, past drug history or concomitant medications.     On 15-DEC-2020, the patient was vaccinated with an improperly stored dose of  hepatitis b vaccine (recombinant) (RECOMBIVAX HB) vial, lot # R028528 expiring on 04-JUN-2021 for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported).   The administered dose of the vaccine experienced a temperature excursion of 10 degrees Celsius for 1 hours and 30 minutes, as recorded by a data logger. The vaccine had not had any previous temperature excursions.  There was no adverse effect reported. No product quality complaint was involved.
Age: 14.0
Sex: M
Vaccine: HEPA
Symptoms: Expired product administered
Clinical narrative: No adverse events; Expired VAQTA was administered; This spontaneous report was received from an office manager referring to a 14 year old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 18-DEC-2020, the patient was vaccinated with a dose of  hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, lot # S032055, for prophylaxis (dose, route and site of vaccination were not provided) which had expired on 01-NOV-2020.  The reporter stated that there was not confusion just human error. The dose was stored at the appropriate storage condition, specified in the product label, through the date of administration.  There was no adverse effect reported. No product quality complaint was involved. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S032055; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Age: 16.0
Sex: U
Vaccine: HPV9
Symptoms: Product storage error
Clinical narrative: no additional averse events; GARDASIL 9 was administered during a temperature excursion; This spontaneous report was received from a Certified Medical Assistant referring to a 16 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 17-NOV-2020, the patient was vaccinated with an improperly stored dose of  hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) pre-filled syringe, lot # S008153 expiring on 20-NOV-2021, for prophylaxis (dose, route and site of administration, lot number and expiration date were not reported).  The administered dose of the vaccine experienced a temperature excursion of 48.4F and 32.7F for 15 minutes and 47 hours, respectively, as recorded by a data logger. The vaccine had not had any previous temperature excursions.  There was no adverse effect reported. No product quality complaint was involved.   combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S008153; expirationdate: 20-NOV-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Age: 71.0
Sex: U
Vaccine: PNC13, PPV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; received PREVNAR 13 when they should have received PNEUMOVAX 23; This spontaneous report was received from a pharmacist referring to a 72 years old patient. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.     On 08-OCT-2019, the patient was vaccinated with the first dose of pneumococcal 13v conj vaccine (crm197) (PREVNAR 13). On 17-SEP-2020, the patient was vaccinated with pneumococcal 13v conj vaccine (crm197) (PREVNAR 13) (1 dose, lot# cm1131 with expiration date30-APR-2022; route and indication were not reported) instead of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (wrong product administered). The patient did not have any other adverse events.
Age: 1.0
Sex: U
Vaccine: HEPA
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; an expired, administered vaccine; This spontaneous report was received from a nurse referring to a 19 months old patient of unknown gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.     On 14-DEC-2020, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) (0.5 milliliter, once, lot # S032055 with expiration date 09-NOV-2020; route was not reported) for prophylaxis (expired product administered). The dose was supported by post-expiry memo and had not undergone a temperature excursion. No additional adverse event. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S032055; expirationdate: 09-NOV-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Age: 1.0
Sex: F
Vaccine: MMR
Symptoms: No adverse event, Syringe issue, Underdose
Clinical narrative: No additional AEs no PQCs; the consumer did not get the full dose as "about 6 drops of the product dripped out on to the patients leg"; Route of Administration: IM; the consumer did not get the full dose as "about 6 drops of the product dripped out on to the patients leg"; This spontaneous report was received from a licensed vocational nurse (LVN) and refers to 12-month-old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 18-DEC-2020 (also reported as today), the patient was vaccinated with a dose of measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (recombinant human albumin (rHA)) (M-M-R II) intramuscularly (IM) to the thigh, lot # S032036, expiration date 10-OCT-2021 (exact dose was not provided) for routine vaccination. It was confirmed that the administered vaccine was lyophilized, reconstituted with the appropriate diluent and drawn up in a Covidien syringe. After the injection, the pressure from the thigh muscle forced the medication to drip out (reported as about 6 drops of the product dripped out onto the patients leg) and the patient did not get the full dose of the vaccine. No lab diagnostics studies were performed. No adverse events (AEs) were reported.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Little soreness; This case was reported by a consumer via call center representative and described the occurrence of pain in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 15th September 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain. On an unknown date, the outcome of the pain was recovered/resolved.   It was unknown if the reporter considered the pain to be related to Shingrix.  Additional details were provided as follows: The patient received the 1st dose of Shingrix in left arm. The patient experienced a little soreness which went away. For the tolerability of 2nd dose, refer case US2020230711 reported for same patient. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020230711:2nd dose
Sex: U
Vaccine: FLUX
Symptoms: Influenza like illness
Clinical narrative: flu-like symptoms; This case was reported by a consumer via interactive digital media and described the occurrence of influenza-like symptoms in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not applicable. The only time in the last 20 years the patient had flu-like symptoms was the one time The patient decided to take the flu vaccine.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Injection site erythema, Rash erythematous
Clinical narrative: Redness at injection site; headache; Pink rash; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 17th November 2020, the patient received the 2nd dose of Shingrix (intramuscular). In November 2020, less than a week after receiving Shingrix, the patient experienced injection site erythema, red rash and headache. In November 2020, the outcome of the injection site erythema and headache were recovered/resolved. On an unknown date, the outcome of the red rash was unknown.   It was unknown if the reporter considered the injection site erythema, red rash and headache to be related to Shingrix.  Additional details were provided as follows: After receiving the 2nd dose of Shingrix in right arm the patient experienced had redness at injection site which was now a light pink rash, the patient also had a headache which was gone. For the tolerability of 1st dose, refer case US2020AMR231743 reported for same patient. The reporter did not consent to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR231743:1st dose
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Injection site pain, Injection site swelling, Injection site urticaria
Clinical narrative: Wheals / at the site of injection; Swelling / at the site of injection; Soreness at the site of injection; Fatigue; This case was reported by a consumer via call center representative and described the occurrence of injection site wheal in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Concurrent medical conditions included neuralgia. Concomitant products included gabapentin.   On 29th July 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced injection site wheal, injection site swelling, injection site pain and fatigue. On an unknown date, the outcome of the injection site wheal, injection site swelling, injection site pain and fatigue were recovered/resolved.   It was unknown if the reporter considered the injection site wheal, injection site swelling, injection site pain and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient had wheals, swelling and soreness at the site of injection and fatigue, which resolved in about 48 hours. The reporter consented to follow up. For tolerance of 2nd dose refer case US2020AMR232727. This case has been linked with US2020231829 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR232727:Same reporter. 2nd dose US-GLAXOSMITHKLINE-US2020231829:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Intense swelling  / Swelling under injection site; red under injection site; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site swelling and injection site erythema were unknown.   It was unknown if the reporter considered the injection site swelling and injection site erythema to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not applicable. The reporter noticed that Shingrix tends to cause more intense swelling than other vaccines.  The only other vaccine reporter stated he sees this was with pneumovax. He stated red swelling under the injection site was common and that he had reported these events several times before but did not anymore.  He observed that it tends occur more often in patients who had prior history of herpes zoster and was wondering if there was any correlation.  No additional information was available to collect. The reporter consented to follow up.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Paraesthesia
Clinical narrative: jabbing pain; had a shingles episode after first dose; Tingling to the left scapula; This case was reported by a physician via call center representative and described the occurrence of shingles in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th October 2020, the patient received the 1st dose of Shingrix. On 16th October 2020, 4 days after receiving Shingrix, the patient experienced shingles and tingling. On 17th October 2020, the patient experienced pain. The patient was treated with valaciclovir hydrochloride (Valtrex). On 21st October 2020, the outcome of the pain was recovered/resolved. On 30th November 2020, the outcome of the tingling was recovered/resolved. On an unknown date, the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the shingles, tingling and pain to be related to Shingrix.  Additional details were provided as follows: The experienced shingles after receiving the 1st dose of Shingrix. The patient started to have tingling sensation on the left scapula on 16th October 2020.  From 17th October 2020 to 21st October 2020, the patient presented jabbing pain instead of tingling and on 22nd October 2020 patient went to the physician, reporter, and physician diagnosed patient with shingles and prescribed Valtrex 1 gram every 8 hours for 7 days. According to reporter, shingles symptoms had abated by time of the report. The reporter consented to follow up.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: got a fever / had a 101 fever /  This morning her fever is 100.4; This case was reported by a consumer via call center representative and described the occurrence of fever in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th November 2020 12:30, the patient received the 1st dose of Shingrix. On 29th November 2020, less than a day after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was not recovered/not resolved.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The patient received the 1st dose around 12:30 PM in her upper left arm. By dinner time, the patient got a fever. She took her temperature in the middle of the night and she had a 101 degree F fever. On 30th November 2020, her fever was 100.4 degree F. The reporter consented to follow up.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Illness, Rash pruritic
Clinical narrative: Really sick / had to stay in bed; Chills; itchy rash on her left leg near her ankle; This case was reported by a consumer via call center representative and described the occurrence of sickness in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In November 2020, 2 days after receiving Shingrix, the patient experienced sickness, chills and itchy rash. On an unknown date, the outcome of the sickness, chills and itchy rash were recovering/resolving.   The reporter considered the sickness, chills and itchy rash to be related to Shingrix.  Additional details were provided as follows: The patient received the 2nd dose of Shingrix about 2 weeks ago.  2 days after vaccination, she states she became really sick and had to stay in bed. She also reports having chills.  About a week after vaccination, she then developed an itchy rash on her left leg near her ankle. She states this was starting to resolve but had not completely resolved. The reporter consented to follow up.
Age: 62.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Varicella
Clinical narrative: his left foot and left calf area and it looked like chickenpox / area on the right side of his torso that looked like chickenpox / chickenpox on the patient's left foot, leg and torso; itching on his left foot and left calf area; This case was reported by a consumer via call center representative and described the occurrence of varicella in a 63-year-old male patient who received Herpes zoster (Shingrix) (batch number 75P7G, expiry date 17th April 2022) for prophylaxis.   On 8th September 2020, the patient received the 1st dose of Shingrix (intramuscular). On 9th September 2020, 1 days after receiving Shingrix, the patient experienced varicella and pruritus. On 11th September 2020, the outcome of the varicella and pruritus were recovered/resolved.   It was unknown if the reporter considered the varicella and pruritus to be related to Shingrix.   Additional details were provided as follows: The patient reported himself. The patient reported that he received the first dose of Shingrix vaccine in the left arm.  The patient reported the second night after receiving the vaccine he started itching on his left foot and left calf area and it looked like chickenpox in those areas. On the following day the patient reported he had an area on the right side of his torso that looked like chickenpox. The patient reported he went to the doctor and the doctor confirmed it appeared to be chickenpox on the patient's left foot, leg and torso. The patient reported the chickenpox and itching resolved after about 2 days. The reporter consented to follow up with HCP.
Sex: U
Vaccine: FLUX
Symptoms: Wheelchair user
Clinical narrative: The flu shot put an older friend of mine in a Wheel chair; Initial information received on 02-Dec-2020 regarding an unsolicited valid non-serious case received from a patient's friend (consumer) via social media.  This case involves patient (unknown demographics) for whom the flu shot put the patient in a Wheel chair (wheelchair user) while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was put in a Wheel chair (wheelchair user) unknown latency following the administration of INFLUENZA VACCINE.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: Got the shot 2 months ago an now got the flu; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 04-Dec-2020.  This case involves a patient with unknown demographics who got the flu after flu shot (influneza), while the patient received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via unknown route at an unknown administration site as prophylactic vaccination.  On an unknown date, the patient experienced the flu (influenza), two months following the administration of influenza vaccine.  laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown at the time of reporting.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Headache, Injection site pain, Malaise, Oropharyngeal pain, Pain
Clinical narrative: Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Makes patient sick; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Initial information was received on 06-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves a patient with unknown demography who had sore achy body (pain), fever (pyrexia), severe headache (headache), sore throat (oropharyngeal pain), sore arm at injection site (pain in extremity and vaccination site pain) and patient got sick (illness), while he/she received vaccine INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sore achy body (pain), fever (pyrexia), severe headache (headache), sore throat (oropharyngeal pain), sore arm at injection site (pain in extremity and vaccination site pain) and patient got sick (illness), unknown latency following the administration of INFLUENZA VACCINE.  It was reported that the patient know that the flu vaccine alone contains thimerosal, formaldehyde, aluminum salts, chicken egg protein, gelatin & antibiotics as well as some form of flu virus (different every year).   Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the events was unknown at the time of reporting.  There will be no information on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Pyrexia
Clinical narrative: Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Makes patient sick; Had sore achy body, fever, severe headache, sore throat, sore arm at injection site; Initial information was received on 06-Dec-2020 regarding an unsolicited valid non-serious social media case from a consumer.  This case involves a patient with unknown demography who had sore achy body (pain), fever (pyrexia), severe headache (headache), sore throat (oropharyngeal pain), sore arm at injection site (pain in extremity and vaccination site pain) and patient got sick (illness), while he/she received vaccine INFLUENZA VACCINE.  Medical history, past medical treatments, vaccinations, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sore achy body (pain), fever (pyrexia), severe headache (headache), sore throat (oropharyngeal pain), sore arm at injection site (pain in extremity and vaccination site pain) and patient got sick (illness), unknown latency following the administration of INFLUENZA VACCINE.  It was reported that the patient know that the flu vaccine alone contains thimerosal, formaldehyde, aluminum salts, chicken egg protein, gelatin & antibiotics as well as some form of flu virus (different every year).   Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the events was unknown at the time of reporting.  There will be no information on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: but person can get pretty damn sick after getting one, take it from patient.; Initial information received on 08-Dec-2020 regarding an unsolicited non-valid (unevaluable event) non-serious case received from a consumer.  This case involves a patient who reported that person can get pretty sick after getting one, take it from him/her (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, patient reported that person can get pretty sick after getting one, take it from him/her (illness), (Unknown latency) following the administration of INFLUENZA VACCINE.  Relevant laboratory data was not reported.   It was not reported if the patient received a corrective treatment.  The outcome was reported as Unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: patient got one flu shot in my life and got a horrible case of the flu; Initial information received on 10-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case was linked with 2020SA356005 (same reporter).  This case involves a patient of unknown age who got one flu shot in my life and got a horrible case of the flu (influenza), while being received vaccine influenza vaccine.  Medical history, past medical treatment, vaccination, family history and concomitant medication were not reported.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient got one flu shot in my life and got a horrible case of the flu (influenza).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: FLUX
Symptoms: Influenza, Vomiting
Clinical narrative: flu; Initial information was received on 10-Dec-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient) via social media.   This case involves a patient (age and gender unspecified) who experienced flu (influenza), while the patient received INFLUENZA VACCINE.  The patient's past vaccination(s) included flu shot (INFLUENZA VACCINE) for prophylactic vaccination. It was reported as patient had with gotten flu shot for years.  Medical history, medical treatment, family history and concomitant medication/therapy were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other doing details not reported] for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported as the patient had the flu one year and thought it going to up shuck his/her guts out.   Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Allergy to vaccine
Clinical narrative: were allergic do it; Initial information was received on 12-Dec-2020 regarding an unsolicited valid non-serious case from a consumer or non-health care professional (patient) via social media.  This case involves a patient (age and gender unspecified) who were allergic do it (allergy to vaccine), while patient received INFLUENZA VACCINE.  Medical history, medical treatment, vaccination, family history and concomitant medication/therapy were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number, expiry date and other dosing details not reported] for prophylactic vaccination.  The patient developed allergic to do it (allergy to vaccine) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for reported events.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: sick; Initial information was received on 13-Dec-2020 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves patient (unknown demographic) who had sick (illness), while patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), past vaccination(s) concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date were not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory data was not provided.  It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Feeling abnormal
Clinical narrative: almost killed me; Initial information received on 15-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown age who reported almost killed the patient (feeling abnormal), while being received vaccine influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient was almost killed (feeling abnormal).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: the shingles shots made me sick; Initial information received on 15-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient of unknown age who reported the shingles shots made patient sick (illness), while being received vaccine influenza vaccine.  Vaccination(s) included Influenza Vaccine.  Medical history, medical treatment(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, it was reported that the shingles shots made patient sick (illness). The last one was the worse but it was worth it if it prevents me from getting shingles.  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: flu; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient (age and gender unspecified) who had flu (Influenza), when received INFLUENZA VACCINE.  Medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date (this year and last year), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (Influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   The patient have not seen any significant number there yet. Patient took flu shot this year and last year just before got the flu.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Influenza
Clinical narrative: flu; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (age and gender unspecified) who had flu (Influenza), when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (Influenza) (unknown latency) following the administration of INFLUENZA VACCINE.   Only time patient get the flu, when he/she get the shot.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: The last time patient got the flu shot and pneumonia shot, patient was never so sick in patients life; Initial information received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/ non-health care professional via social media.  This case involves a patient of unknown age who was never so sick in patients' life (influenza), while being received vaccine influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, the last time patient got the flu shot and pneumonia shot, patient was never so sick in patients' life (influenza).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: FLUX
Symptoms: Hypersensitivity
Clinical narrative: Allergic to many things; Initial information was received on 15-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (age and gender unspecified) who had allergic reaction (hypersensitivity) when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious allergic reaction (hypersensitivity) (unknown latency) following the administration of INFLUENZA VACCINE.   Allergic to might things including flu shots  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Sex: U
Vaccine: FLUX
Symptoms: Feeling abnormal, Malaise
Clinical narrative: 9 out of 11 were bad sick within 2 days; Initial information received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/ non-health care professional via social media.  This case involves a 11 patient of unknown age in which 9 were bad sick within 2 days (illness), while being received vaccine influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, it was reported 9 out of 11 were bad sick within 2 days (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case.
Sex: U
Vaccine: FLUX
Symptoms: Pain in extremity
Clinical narrative: all I had was a little sore arm; Initial information was received on 17-Dec-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves a patient (age and gender unspecified) who had a little sore arm (pain in extremity), when received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious little sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.